Header Logo

Connection

SHELDON KAPLAN to Staphylococcus aureus

Back to Details
This is a "connection" page, showing publications SHELDON KAPLAN has written about Staphylococcus aureus.
SHELDON KAPLAN
Connection Strength
8.725
Staphylococcus aureus
  1. Penicillin susceptibility among Staphylococcus aureus skin and soft tissue infections at a children's hospital. Microbiol Spectr. 2024 Oct 03; 12(10):e0086924.
    View in: PubMed
    Score: 0.701
  2. Staphylococcus aureus Infections in Children: The Implications of Changing Trends. Pediatrics. 2016 04; 137(4).
    View in: PubMed
    Score: 0.388
  3. Clinical and Molecular Features of Decreased Chlorhexidine Susceptibility among Nosocomial Staphylococcus aureus Isolates at Texas Children's Hospital. Antimicrob Agents Chemother. 2016 Feb; 60(2):1121-8.
    View in: PubMed
    Score: 0.383
  4. Staphylococcus aureus retropharyngeal abscess in children. Pediatr Infect Dis J. 2015 Apr; 34(4):454-6.
    View in: PubMed
    Score: 0.364
  5. Community-associated Staphylococcus aureus infections in otherwise healthy infants less than 60 days old. Pediatr Infect Dis J. 2014 Jan; 33(1):98-100.
    View in: PubMed
    Score: 0.334
  6. Recurrent community-associated Staphylococcus aureus infections in children presenting to Texas Children's Hospital in Houston, Texas. Pediatr Infect Dis J. 2013 Nov; 32(11):1189-93.
    View in: PubMed
    Score: 0.330
  7. Clinical and molecular epidemiology of Staphylococcus aureus catheter-related bacteremia in children. Pediatr Infect Dis J. 2010 May; 29(5):410-4.
    View in: PubMed
    Score: 0.259
  8. USA300 is the predominant genotype causing Staphylococcus aureus septic arthritis in children. Pediatr Infect Dis J. 2009 Dec; 28(12):1076-80.
    View in: PubMed
    Score: 0.252
  9. Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005. J Clin Microbiol. 2009 Jun; 47(6):1628-30.
    View in: PubMed
    Score: 0.242
  10. Pediatric antibody response to community-acquired Staphylococcus aureus infection is directed to Panton-Valentine leukocidin. Clin Vaccine Immunol. 2009 Jan; 16(1):139-41.
    View in: PubMed
    Score: 0.234
  11. Evaluation and treatment of community-acquired Staphylococcus aureus infections in term and late-preterm previously healthy neonates. Pediatrics. 2007 Nov; 120(5):937-45.
    View in: PubMed
    Score: 0.218
  12. Community-acquired Staphylococcus aureus infections in term and near-term previously healthy neonates. Pediatrics. 2006 Sep; 118(3):874-81.
    View in: PubMed
    Score: 0.201
  13. Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2006 Oct 15; 43(8):953-60.
    View in: PubMed
    Score: 0.201
  14. Community-acquired methicillin-resistant Staphylococcus aureus infections in children. Semin Pediatr Infect Dis. 2006 Jul; 17(3):113-9.
    View in: PubMed
    Score: 0.199
  15. Venous thrombosis associated with staphylococcal osteomyelitis in children. Pediatrics. 2006 May; 117(5):1673-9.
    View in: PubMed
    Score: 0.196
  16. Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children. Pediatrics. 2006 Feb; 117(2):433-40.
    View in: PubMed
    Score: 0.193
  17. Implications of methicillin-resistant Staphylococcus aureus as a community-acquired pathogen in pediatric patients. Infect Dis Clin North Am. 2005 Sep; 19(3):747-57.
    View in: PubMed
    Score: 0.188
  18. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis. 2005 Jun 15; 40(12):1785-91.
    View in: PubMed
    Score: 0.183
  19. Treatment of community-associated methicillin-resistant Staphylococcus aureus infections. Pediatr Infect Dis J. 2005 May; 24(5):457-8.
    View in: PubMed
    Score: 0.183
  20. Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics. 2005 Mar; 115(3):642-8.
    View in: PubMed
    Score: 0.181
  21. The Utilization of Echocardiography in Children With Staphylococcus aureus Bacteremia. J Pediatric Infect Dis Soc. 2024 Nov 04; 13(10):537-540.
    View in: PubMed
    Score: 0.177
  22. Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J. 2003 Sep; 22(9 Suppl):S178-85.
    View in: PubMed
    Score: 0.163
  23. Infectious disease consultation in children with S. aureus Bacteremia: does it improve patient outcomes and quality of care? Pediatr Res. 2022 12; 92(6):1502-1503.
    View in: PubMed
    Score: 0.153
  24. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J. 2002 Oct; 21(10):910-7.
    View in: PubMed
    Score: 0.153
  25. Follow-up Blood Cultures in Children With Staphylococcus aureus Bacteremia. Pediatrics. 2020 12; 146(6).
    View in: PubMed
    Score: 0.135
  26. Adhesin genes and biofilm formation among pediatric Staphylococcus aureus?isolates from implant-associated infections. PLoS One. 2020; 15(6):e0235115.
    View in: PubMed
    Score: 0.131
  27. Increasing Numbers of Staphylococcal Scalded Skin Syndrome Cases Caused by ST121 in Houston, Texas. Pediatr Infect Dis J. 2020 01; 39(1):30-34.
    View in: PubMed
    Score: 0.127
  28. Clinical and Microbiologic Variables Predictive of Orthopedic Complications Following Staphylococcus aureus Acute Hematogenous Osteoarticular Infections in Children. Clin Infect Dis. 2019 11 13; 69(11):1955-1961.
    View in: PubMed
    Score: 0.125
  29. Comparison of Musculoskeletal Infections due to Nontyphoidal Salmonella Species and Staphylococcus aureus in Immunocompetent Children. Pediatr Infect Dis J. 2019 10; 38(10):1020-1024.
    View in: PubMed
    Score: 0.124
  30. Clinical Characteristics and Outcomes of Staphylococcus aureus Implant-associated Infections in Children. Pediatr Infect Dis J. 2019 08; 38(8):808-811.
    View in: PubMed
    Score: 0.123
  31. Molecular Characterization of Staphylococcus aureus Isolates From Children With Periorbital or Orbital Cellulitis. J Pediatric Infect Dis Soc. 2018 Aug 17; 7(3):205-209.
    View in: PubMed
    Score: 0.115
  32. Association of Vancomycin MIC and Molecular Characteristics with Clinical Outcomes in Methicillin-Susceptible Staphylococcus aureus Acute Hematogenous Osteoarticular Infections in Children. Antimicrob Agents Chemother. 2018 05; 62(5).
    View in: PubMed
    Score: 0.113
  33. Impact of Health Care Exposure on Genotypic Antiseptic Tolerance in Staphylococcus aureus Infections in a Pediatric Population. Antimicrob Agents Chemother. 2017 07; 61(7).
    View in: PubMed
    Score: 0.106
  34. Healthcare-associated Staphylococcus aureus Bacteremia in Children: Evidence for Reverse Vancomycin Creep and Impact of Vancomycin Trough Values on Outcome. Pediatr Infect Dis J. 2016 Mar; 35(3):263-8.
    View in: PubMed
    Score: 0.097
  35. Characterization of Staphylococcus aureus infections in children with Down syndrome. J Infect Chemother. 2015 Nov; 21(11):790-4.
    View in: PubMed
    Score: 0.094
  36. Staphylococcus aureus infections among children receiving a solid organ transplant: clinical features, epidemiology, and antimicrobial susceptibility. Transpl Infect Dis. 2015 Feb; 17(1):39-47.
    View in: PubMed
    Score: 0.090
  37. Staphylococcus aureus bacteremia without a localizing source in pediatric patients. Pediatr Infect Dis J. 2014 May; 33(5):e132-4.
    View in: PubMed
    Score: 0.085
  38. Meningitis due to Staphylococcus aureus in children. Clin Infect Dis. 1993 Jun; 16(6):766-71.
    View in: PubMed
    Score: 0.080
  39. Staphylococcus aureus infections in pediatric oncology patients: high rates of antimicrobial resistance, antiseptic tolerance and complications. Pediatr Infect Dis J. 2013 Feb; 32(2):124-8.
    View in: PubMed
    Score: 0.078
  40. Staphylococcus aureus infections in pediatric patients with diabetes mellitus. J Infect. 2012 Aug; 65(2):135-41.
    View in: PubMed
    Score: 0.074
  41. Constitutive production of catalytic antibodies to a Staphylococcus aureus virulence factor and effect of infection. J Biol Chem. 2012 Mar 23; 287(13):9940-9951.
    View in: PubMed
    Score: 0.073
  42. Mupirocin resistance in Staphylococcus aureus causing recurrent skin and soft tissue infections in children. Antimicrob Agents Chemother. 2011 May; 55(5):2431-3.
    View in: PubMed
    Score: 0.068
  43. Nasal Staphylococcus aureus colonization among mothers of term and late preterm previously healthy neonates with community-acquired Staphylococcus aureus infections. Pediatr Infect Dis J. 2011 Jan; 30(1):74-6.
    View in: PubMed
    Score: 0.068
  44. Commentary: Prevention of recurrent staphylococcal infections. Pediatr Infect Dis J. 2008 Oct; 27(10):935-7.
    View in: PubMed
    Score: 0.058
  45. Increase of the USA300 clone among community-acquired methicillin-susceptible Staphylococcus aureus causing invasive infections. Pediatr Infect Dis J. 2007 Dec; 26(12):1122-7.
    View in: PubMed
    Score: 0.055
  46. Subtle genetic changes enhance virulence of methicillin resistant and sensitive Staphylococcus aureus. BMC Microbiol. 2007 Nov 06; 7:99.
    View in: PubMed
    Score: 0.055
  47. Three-year surveillance of community onset health care-associated staphylococcus aureus infections in children. Pediatr Infect Dis J. 2006 Apr; 25(4):349-53.
    View in: PubMed
    Score: 0.049
  48. Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin Infect Dis. 2005 Sep 01; 41(5):583-90.
    View in: PubMed
    Score: 0.047
  49. Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas. Pediatr Infect Dis J. 2005 Mar; 24(3):201-6.
    View in: PubMed
    Score: 0.045
  50. Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children. Pediatr Infect Dis J. 2004 Aug; 23(8):701-6.
    View in: PubMed
    Score: 0.043
  51. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J. 2003 Jul; 22(7):593-8.
    View in: PubMed
    Score: 0.040
  52. Predictive Factors to Guide Empiric Antimicrobial Therapy of Acute Hematogenous Osteomyelitis in Children. Pediatr Infect Dis J. 2023 06 01; 42(6):449-455.
    View in: PubMed
    Score: 0.039
  53. Going Back in Time: Increasing Penicillin Susceptibility among Methicillin-Susceptible Staphylococcus aureus Osteoarticular Infections in Children. Antimicrob Agents Chemother. 2023 01 24; 67(1):e0119622.
    View in: PubMed
    Score: 0.039
  54. The Indirect Impact of the SARS-CoV-2 Pandemic on Invasive Group a Streptococcus, Streptococcus Pneumoniae and Staphylococcus Aureus Infections in Houston Area Children. Pediatr Infect Dis J. 2021 08 01; 40(8):e313-e316.
    View in: PubMed
    Score: 0.035
  55. Cefazolin Inoculum Effect and Methicillin-Susceptible Staphylococcus aureus Osteoarticular Infections in Children. Antimicrob Agents Chemother. 2020 08 20; 64(9).
    View in: PubMed
    Score: 0.033
  56. Microbiology of Osteoarticular Infections in Patients with Sickle Hemoglobinopathies at Texas Children's Hospital, 2000-2018. Pediatr Infect Dis J. 2019 12; 38(12):1251-1253.
    View in: PubMed
    Score: 0.031
  57. The prevalence of antiseptic tolerance genes among staphylococci and enterococci in a pediatric population. Infect Control Hosp Epidemiol. 2019 03; 40(3):333-340.
    View in: PubMed
    Score: 0.030
  58. Staphylococcus aureus Central Nervous System Infections in Children. Pediatr Infect Dis J. 2017 Oct; 36(10):947-951.
    View in: PubMed
    Score: 0.027
  59. A Randomized, Prospective Study of Pediatric Patients With Community-acquired Pneumonia Treated With Ceftaroline Versus Ceftriaxone. Pediatr Infect Dis J. 2016 07; 35(7):752-9.
    View in: PubMed
    Score: 0.025
  60. Decreased susceptibilities to Retapamulin, Mupirocin, and Chlorhexidine among Staphylococcus aureus isolates causing skin and soft tissue infections in otherwise healthy children. Antimicrob Agents Chemother. 2014 May; 58(5):2878-83.
    View in: PubMed
    Score: 0.021
  61. Staphylococcus aureus infections in HIV-positive children and adolescents. Pediatr Infect Dis J. 2012 Mar; 31(3):284-6.
    View in: PubMed
    Score: 0.018
  62. Staphylococcus aureus sinus infections in children. Int J Pediatr Otorhinolaryngol. 2011 Jan; 75(1):118-21.
    View in: PubMed
    Score: 0.017
  63. Outcome of heteroresistant Staphylococcus aureus infections in children. J Infect Dis. 1987 Jul; 156(1):205-8.
    View in: PubMed
    Score: 0.013
  64. The changing face of pleural empyemas in children: epidemiology and management. Pediatrics. 2004 Jun; 113(6):1735-40.
    View in: PubMed
    Score: 0.011
  65. Rapid identification of the invading microorganism. Pediatr Clin North Am. 1980 Nov; 27(4):783-803.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.